ETFs

Telecom Stocks To Follow Today – March 10th

Broadcom, ServiceNow, AT&T, Arista Networks, CRH, Palo Alto Networks, and Apollo...

Galecto (GLTO) Projected to Post Quarterly Earnings on ...

Galecto (NASDAQ:GLTO – Get Free Report) is expected to be announcing its earning...

Buckle (BKE) Projected to Post Earnings on Friday

Buckle (NYSE:BKE – Get Free Report) is projected to post its quarterly earnings ...

Entera Bio (ENTX) Expected to Announce Earnings on Friday

Entera Bio (NASDAQ:ENTX – Get Free Report) is projected to release its earnings ...

Structure Therapeutics (GPCR) to Release Earnings on Fr...

Structure Therapeutics (NASDAQ:GPCR – Get Free Report) is projected to post its ...

OptimumBank (OPHC) to Release Earnings on Friday

OptimumBank (NASDAQ:OPHC – Get Free Report) is anticipated to issue its quarterl...

Stephens Issues Pessimistic Forecast for ModivCare (NAS...

ModivCare (NASDAQ:MODV – Get Free Report) had its target price cut by research a...

Lazydays (GORV) Expected to Announce Earnings on Friday

Lazydays (NASDAQ:GORV – Get Free Report) is anticipated to announce its earnings...

BMO Capital Markets Forecasts Strong Price Appreciation...

Okta (NASDAQ:OKTA – Get Free Report) had its price objective boosted by investme...

O’Reilly Automotive (NASDAQ:ORLY) Earns “Buy” Rating fr...

O’Reilly Automotive (NASDAQ:ORLY – Get Free Report)‘s stock had its “buy” rating...

RAPT Therapeutics’ (RAPT) Buy Rating Reaffirmed at HC W...

RAPT Therapeutics (NASDAQ:RAPT – Get Free Report)‘s stock had its “buy” rating r...

Barclays Issues Pessimistic Forecast for Old Dominion F...

Old Dominion Freight Line (NASDAQ:ODFL – Get Free Report) had its price objectiv...

ProQR Therapeutics (NASDAQ:PRQR) Stock Rating Upgraded ...

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by investment an...

Methanex (NASDAQ:MEOH) Cut to “Sector Perform” at Scoti...

Methanex (NASDAQ:MEOH – Get Free Report) (TSE:MX) was downgraded by analysts at ...

Orchestra BioMed’s (OBIO) “Buy” Rating Reiterated at HC...

Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating re...

Immunome’s (IMNM) “Outperform” Rating Reaffirmed at Wed...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating rei...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.